Literature DB >> 29430571

Bayesian Cox Proportional Hazards Model in Survival Analysis of HACE1 Gene with Age at Onset of Alzheimer's Disease.

Ke-Sheng Wang1, Ying Liu1, Shaoqing Gong2, Chun Xu3, Xin Xie4, Liang Wang1, Xingguang Luo5,6.   

Abstract

Alzheimer's disease (AD), the most common form of dementia, is a chronic neurodegenerative disease. The HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 (HACE1) gene is expressed in human brain and may play a role in the pathogenesis of neurodegenerative disorders. Till now, no previous study has reported the association of the HACE1 gene with the risk and age at onset (AAO) of AD; while few studies have checked the proportional hazards assumption in the survival analysis of AAO of AD using Cox proportional hazards model. In this study, we examined the associations of 14 single nucleotide polymorphisms (SNPs) in the HACE1 gene with the risk and the AAO of AD using 791 AD patients and 782 controls. Multiple logistic regression model identified one SNP (rs9499937 with p = 1.8×10-3) to be associated with the risk of AD. For survival analysis of AAO, both classic Cox regression model and Bayesian survival analysis using the Cox proportional hazards model were applied to examine the association of each SNP with the AAO. The hazards ratio (HR) with its 95% confidence interval (CI) was estimated. Survival analysis using the classic Cox regression model showed that 4 SNPs were significantly associated with the AAO (top SNP rs9499937 with HR=1.33, 95%CI=1.13-1.57, p=5.0×10-4). Bayesian Cox regression model showed similar but a slightly stronger associations (top SNP rs9499937 with HR=1.34, 95%CI=1.11-1.55) compared with the classic Cox regression model. Using an independent family-based sample, one SNP rs9486018 was associated with the risk of AD (p=0.0323) and the T-T-G haplotype from rs9786015, rs9486018 and rs4079063 showed associations with both the risk and AAO of AD (p=2.27×10-3 and 0.0487, respectively). The findings of this study provide first evidence that several genetic variants in the HACE1 gene were associated with the risk and AAO of AD.

Entities:  

Keywords:  Age at onset; Alzheimer’s disease; Bayesian analysis; Cox model; HACE1; Single nucleotide polymorphisms; Survival analysis

Year:  2017        PMID: 29430571      PMCID: PMC5806706          DOI: 10.23937/2469-5831/1510014

Source DB:  PubMed          Journal:  Int J Clin Biostat Biom


  53 in total

1.  Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype.

Authors:  Kyung-Won Hong; Kwang-Pil Ko; Younjhin Ahn; Cheong-Sik Kim; Seon-Joo Park; Jae Kyung Park; Sung Soo Kim; Yeonjung Kim
Journal:  Genes Nutr       Date:  2012-04-03       Impact factor: 5.523

2.  Prevalence of Alzheimer disease in US states.

Authors:  Jennifer Weuve; Liesi E Hebert; Paul A Scherr; Denis A Evans
Journal:  Epidemiology       Date:  2015-01       Impact factor: 4.822

Review 3.  Immune attack: the role of inflammation in Alzheimer disease.

Authors:  Frank L Heppner; Richard M Ransohoff; Burkhard Becher
Journal:  Nat Rev Neurosci       Date:  2015-06       Impact factor: 34.870

Review 4.  The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy.

Authors:  Zofia Blach-Olszewska; Ewa Zaczynska; Kasia Gustaw-Rothenberg; Marco Avila-Rodrigues; George E Barreto; Jerzy Leszek; Gjumrakch Aliev
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  Multiple independent variants in 6q21-22 associated with susceptibility to celiac disease in the Dutch, Finnish and Hungarian populations.

Authors:  Elisabet Einarsdottir; Marianna R Bevova; Alexandra Zhernakova; Alienke Monsuur; Lotta L E Koskinen; Ruben van't Slot; Chris Mulder; M Luisa Mearin; Ilma R Korponay-Szabo; Katri Kaukinen; Kalle Kurppa; Juha Kere; Markku Mäki; Cisca Wijmenga; Päivi Saavalainen
Journal:  Eur J Hum Genet       Date:  2011-02-16       Impact factor: 4.246

6.  Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.

Authors:  Joseph H Lee; Rong Cheng; Neill Graff-Radford; Tatiana Foroud; Richard Mayeux
Journal:  Arch Neurol       Date:  2008-11

Review 7.  Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease.

Authors:  Adrianne S Chesser; Susanne M Pritchard; Gail V W Johnson
Journal:  Front Neurol       Date:  2013-09-03       Impact factor: 4.003

8.  HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.

Authors:  Liyong Zhang; Xin Chen; Parveen Sharma; Mark Moon; Alex D Sheftel; Fayez Dawood; Mai P Nghiem; Jun Wu; Ren-Ke Li; Anthony O Gramolini; Poul H Sorensen; Josef M Penninger; John H Brumell; Peter P Liu
Journal:  Nat Commun       Date:  2014-03-11       Impact factor: 14.919

9.  HACE1 deficiency causes an autosomal recessive neurodevelopmental syndrome.

Authors:  Ronja Hollstein; David A Parry; Lisa Nalbach; Clare V Logan; Tim M Strom; Verity L Hartill; Ian M Carr; Georg C Korenke; Sandeep Uppal; Mushtaq Ahmed; Thomas Wieland; Alexander F Markham; Christopher P Bennett; Gabriele Gillessen-Kaesbach; Eamonn G Sheridan; Frank J Kaiser; David T Bonthron
Journal:  J Med Genet       Date:  2015-09-30       Impact factor: 6.318

10.  HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.

Authors:  Barak Rotblat; Amber L Southwell; Dagmar E Ehrnhoefer; Niels H Skotte; Martina Metzler; Sonia Franciosi; Gabriel Leprivier; Syam Prakash Somasekharan; Adi Barokas; Yu Deng; Tiffany Tang; Joan Mathers; Naniye Cetinbas; Mads Daugaard; Brian Kwok; Liheng Li; Christopher J Carnie; Dieter Fink; Roberto Nitsch; Jason D Galpin; Christopher A Ahern; Gerry Melino; Josef M Penninger; Michael R Hayden; Poul H Sorensen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

View more
  1 in total

1.  Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods.

Authors:  Song Zhai; Hong Zhang; Devan V Mehrotra; Judong Shen
Journal:  Nat Commun       Date:  2022-09-08       Impact factor: 17.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.